Selected recent publications
Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kayentao K, Ouma P, Coulibaly SO, Kalilani L, Mace KE, Arinaitwe E, Mathanga DP, Doumbo O, Otieno K, Edgar D, Chaluluka E, Kamuliwo M, Ades V, Skarbinski J, Ya Ping S, Magnussen P, Meshnick S, Ter Kuile FO (submitted). Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight: A prospective, multi-country observational study across Africa.
Gutman J, Madanitsa M, Khairallah C, L’lanziva A, Kalilani L, Otieno K, Mwapasa V, Taylor SM, Meshnick S, Wang D, Desai M, Ter Kuile FO. Intermittent screening and treatment with dihydroartemisinin-piperaquine is inferior to intermittent preventive treatment with sulphadoxine-pyrimethamine for the control of malaria in pregnancy in Malawi and Kenya: results from an individual pooled analysis of randomized clinical trials. Lancet. 2015 Sep 28. pii: S0140-6736(15)00310-4. doi: 10.1016/S0140-6736(15)00310-4. [Epub ahead of print]
Taylor SM, Antonia AL, Harrington WE, Goheen MM, Mwapasa V, Chaluluka E, Fried M, Kabyemela E, Madanitsa M, Khairallah C, Kalilani-Phiri L, Tshefu AK, Rogerson SJ, Ter Kuile FO, Duffy PE, Meshnick SR (2014). Independent lineages of highly sulfadoxine-resistant Plasmodium falciparum haplotypes, eastern Africa. Emerg Infect Dis. 2014 Jul;20(7):1140-8.
Coulibaly SO, Kayentao K, Taylor S, Guirou EA, Khairallah C, Guindo N, Djimde M, Bationo R, Soulama A, Dabira E, Barry B, Niangaly M, Diakite H, Konate S, Keita M, Traore B, Meshnick SR, Magnussen P, Doumbo OK, ter Kuile FO (2014). Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day in vivo follow-up study. Malar J. 2014 Jan 31;13:41.
Phiri K, Esan M, van Hensbroek MB, Khairallah C, Faragher B, ter Kuile FO (2011). Intermittent preventive therapy for malaria with monthly artemether-lumefantrine for the post-discharge management of severe anaemia in children aged 4-59 months in southern Malawi: a multicentre, randomised, placebo-controlled trial. Lancet Infect Dis. 2012 Mar;12(3):191-200.